These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 8864800)

  • 21. Long-term activity of clopidogrel: a three-month appraisal in healthy volunteers.
    Caplain H; Cariou R
    Semin Thromb Hemost; 1999; 25 Suppl 2():21-4. PubMed ID: 10440418
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of platelet aggregation by AZD6140, a reversible oral P2Y12 receptor antagonist, compared with clopidogrel in patients with acute coronary syndromes.
    Storey RF; Husted S; Harrington RA; Heptinstall S; Wilcox RG; Peters G; Wickens M; Emanuelsson H; Gurbel P; Grande P; Cannon CP
    J Am Coll Cardiol; 2007 Nov; 50(19):1852-6. PubMed ID: 17980251
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of platelet alpha2-adrenergic receptor activity in stable coronary artery disease patients on dual antiplatelet therapy.
    Béres BJ; Tóth-Zsámboki E; Vargová K; László A; Masszi T; Kerecsen G; Préda I; Kiss RG
    Thromb Haemost; 2008 Nov; 100(5):829-38. PubMed ID: 18989527
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antiplatelet activity of clopidogrel in coronary artery bypass graft surgery patients.
    David JL; Limet R
    Thromb Haemost; 1999 Nov; 82(5):1417-21. PubMed ID: 10595630
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Onset and extent of platelet inhibition by clopidogrel loading in patients undergoing elective coronary stenting: the Plavix Reduction Of New Thrombus Occurrence (PRONTO) trial.
    Gurbel PA; Cummings CC; Bell CR; Alford AB; Meister AF; Serebruany VL;
    Am Heart J; 2003 Feb; 145(2):239-47. PubMed ID: 12595840
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of clopidogrel, aspirin and both antiplatelet drugs on platelet function in patients with peripheral arterial disease.
    Jagroop IA; Matsagas MI; Geroulakos G; Mikhailidis DP
    Platelets; 2004 Mar; 15(2):117-25. PubMed ID: 15154604
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Benefit/risk profile of combined antiplatelet therapy with ticlopidine and aspirin.
    De Caterina R; Sicari R; Bernini W; Lazzerini G; Buti Strata G; Giannessi D
    Thromb Haemost; 1991 May; 65(5):504-10. PubMed ID: 1871711
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibitory effects of ticlopidine on platelet function as assessed by three different methods.
    Cuyun-Lira O; Kaneko M; Takafuta T; Satoh K; Ohnishi M; Yatomi Y; Ozaki Y
    Eur J Pharm Sci; 2007 Jan; 30(1):21-5. PubMed ID: 17070023
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of body mass index on platelet aggregation after administration of a high loading dose of 600 mg of clopidogrel before percutaneous coronary intervention.
    Sibbing D; von Beckerath O; Schömig A; Kastrati A; von Beckerath N
    Am J Cardiol; 2007 Jul; 100(2):203-5. PubMed ID: 17631070
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clopidogrel does not affect the pharmacokinetics of theophylline.
    Caplain H; Thebault JJ; Necciari J
    Semin Thromb Hemost; 1999; 25 Suppl 2():65-8. PubMed ID: 10440427
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Onset and offset of platelet inhibition after high-dose clopidogrel loading and standard daily therapy measured by a point-of-care assay in healthy volunteers.
    Price MJ; Coleman JL; Steinhubl SR; Wong GB; Cannon CP; Teirstein PS
    Am J Cardiol; 2006 Sep; 98(5):681-4. PubMed ID: 16923461
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Monitoring platelet inhibition after clopidogrel with the VerifyNow-P2Y12(R) rapid analyzer: the VERIfy Thrombosis risk ASsessment (VERITAS) study.
    Malinin A; Pokov A; Spergling M; Defranco A; Schwartz K; Schwartz D; Mahmud E; Atar D; Serebruany V
    Thromb Res; 2007; 119(3):277-84. PubMed ID: 16563469
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effectiveness of reloading to overcome clopidogrel nonresponsiveness in patients with acute myocardial infarction.
    Matetzky S; Fefer P; Shenkman B; Varon D; Savion N; Hod H
    Am J Cardiol; 2008 Sep; 102(5):524-9. PubMed ID: 18721506
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of platelet aggregation by aspirin progressively decreases in long-term treated patients.
    Pulcinelli FM; Pignatelli P; Celestini A; Riondino S; Gazzaniga PP; Violi F
    J Am Coll Cardiol; 2004 Mar; 43(6):979-84. PubMed ID: 15028353
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nonpeptide glycoprotein IIb/IIIa inhibitors. 15. Antithrombotic efficacy of L-738,167, a long-acting GPIIb/IIIa antagonist, correlates with inhibition of adenosine diphosphate-induced platelet aggregation but not with bleeding time prolongation.
    Cook JJ; Sitko GR; Holahan MA; Stranieri MT; Glass JD; Askew BC; McIntyre CJ; Claremon DA; Baldwin JJ; Hartman GD; Gould RJ; Lynch JJ
    J Pharmacol Exp Ther; 1997 May; 281(2):677-89. PubMed ID: 9152373
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of ticlopidine of platelet function in men with stable angina pectoris.
    Berglund U; von Schenck H; Wallentin L
    Thromb Haemost; 1985 Dec; 54(4):808-12. PubMed ID: 3911481
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of D-003, a mixture of very long chain fatty acids purified from sugar cane wax, at 5 and 10 mg/day on platelet aggregation in healthy volunteers.
    Arruzazabala ML; Molina V; Carbajal D; Fernández L; Mas R; Castaño G; Illnait J; Mendoza S; Fernańdez J
    Int J Clin Pharmacol Res; 2005; 25(1):29-39. PubMed ID: 15868655
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Platelet cyclooxygenase inhibition by low-dose aspirin is not reflected consistently by platelet function assays: implications for aspirin "resistance".
    Santilli F; Rocca B; De Cristofaro R; Lattanzio S; Pietrangelo L; Habib A; Pettinella C; Recchiuti A; Ferrante E; Ciabattoni G; Davì G; Patrono C
    J Am Coll Cardiol; 2009 Feb; 53(8):667-77. PubMed ID: 19232899
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Measurement of platelet aggregation during antiplatelet therapy in ischemic stroke.
    Pongrácz E
    Clin Hemorheol Microcirc; 2004; 30(3-4):237-42. PubMed ID: 15258349
    [TBL] [Abstract][Full Text] [Related]  

  • 40. How to optimise clopidogrel therapy? Reducing the low-response incidence by aggregometry-guided therapy modification.
    Neubauer H; Lask S; Engelhardt A; Mügge A
    Thromb Haemost; 2008 Feb; 99(2):357-62. PubMed ID: 18278186
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.